We are currently offering only the Pfizer–BioNTech and Moderna COVID-19 vaccines to our eligible patients. We are notifying patients individually when they can schedule a vaccination appointment. Create a MyChart account so we can notify you. Learn more about the COVID-19 vaccine.

If you need help accessing our website, call 855-698-9991
Skip to main content

Ventricular Assist Device Program

We have doctors located in Manhattan.

At NYU Langone’s Ventricular Assist Device (VAD) Program, we offer leading edge, lifesaving mechanical circulatory support for two major conditions: acute cardiogenic shock, in which the heart muscle abruptly stops working, and chronic advanced heart failure, in which the heart muscle is permanently weakened and doesn’t pump blood and oxygen throughout the body efficiently. 

VIDEO: Doctors discuss the benefits of the left ventricular assist device.

After someone experiences acute cardiogenic shock, a temporary left ventricular assist device (LVAD) helps circulate blood throughout the body until the heart recovers. In chronic heart failure, an LVAD can help extend—and improve—the lives of some people, whether you are awaiting heart transplant or you are not a candidate for one. This treatment has been shown to increase patient survival, sometimes by more than five years.


U.S. News & World Report’s “Best Hospitals” ranks NYU Langone one of the top hospitals in the country for cardiology and heart surgery.

Through the VAD Program, NYU Langone offers all LVAD devices approved by the U.S. Food and Drug Administration for treating advanced heart failure. What’s more, our VAD program has earned advanced certification from The Joint Commission, the nation’s oldest and largest standards-setting and accrediting body in healthcare.

Our team of heart failure cardiologists and cardiac surgeons, nurse practitioners, social workers, and other specialists work together to provide personalized care before, during, and after surgery to implant an LVAD. Our experts are available 24 hours a day, 7 days a week, through our dedicated hotline, and we monitor your progress daily to ensure that you are safely taking medications and making lifestyle changes designed to improve your overall health. 

Ventricular Assist Device Clinical Trial

NYU Langone is participating in a clinical trial to evaluate the NuPulse Intravascular Ventricular Assist System, also known as iVAS. The iVAS is placed during a minimally invasive procedure that involves a small incision near the shoulder. The iVAS creates a pumping motion that helps move blood through the descending aorta, which travels through the chest, and to the rest of the body. The iVAS can be used outside the hospital and allows people more mobility than traditional LVAD devices. It is appropriate for people who are not candidates for LVAD and those who are waiting for a heart transplant. 

For more information, including additional eligibility criteria, please contact Dr. Deane E. Smith at 646-501-0151 or Dr. Claudia G. Gidea at 646-501-0119